top of page

Emmanouil Alevroudis

Nuclear Doctor

Dr. Emmanouil Aleuroudis was born in Greece. He studied and received his medical degree at the School of Medicine of the Aristotle University of Thessaloniki. He was trained and worked as a Nuclear Medicine Physician in university hospitals of Thessaloniki and Athens, Greece. 


During his career, he specialized in advanced radioisotope therapeutic methodologies and was included in the Greek Center of Excellence and Expertise for neuroendocrine tumors of the European Neuroendocrine Tumor Society – ENETS. He joined the Department of Nuclear Medicine of the German Oncology Institute in February 2022 and in particular the Radioisotope Application Chamber which provides a complete range of therapeutic applications of Nuclear Medicine with the most personalized and individualized patient management approach.

dct-VhrachimisAl.jpg
Education / Academic Experience

  • Medical Degree, Aristotle University of Thessaloniki.

  • Medical Specialty in Nuclear Medicine, Laboratory of Nuclear Medicine, Ippokrateio General Hospital of Thessaloniki, 2013 – 2018.

  • Scientific collaboration and training at the Positron Emission Tomography (PET/CT) Unit of the Biomedical Research Foundation Academy of Athens (BRFAA) 2017-2018.

  • Researcher in cerebral metabolism and heart failure protocols at the Biomedical Research Foundation Academy of Athens (BRFAA) and at the Second University Cardiology Clinic and Nuclear Medicine Department of the National and Kapodistrian University of Athens General Hospital "Attikon", 2020-2021.

  • Investigator in prospective, multicenter phase III studies.

  • Co-author of nuclear medicine books and monographs.

Professional Experience

  • Medical Specialty in Nuclear Medicine, Laboratory of Nuclear Medicine, Ippokrateio General Hospital of Thessaloniki, 2013 – 2018.

  • Nuclear Medicine Physician, Laboratory of Nuclear Medicine, Ippokrateio General Hospital of Thessaloniki, 2018 – 2019.

  • Nuclear Medicine Physician, Academic Fellow of the National and Kapodistrian University of Athens, Nuclear Medicine Department of the National and Kapodistrian University of Athens General Hospital "Attikon, 2019 – 2022. In charge for peptide receptor radioisotope treatments for neuroendocrine neoplasms and selective internal radiation therapies for primary and secondary hepatic neoplasms.

  • Nuclear Medicine Physician at the Department of Nuclear Medicine of the German Oncology Institute, Limassol, Cyprus, from February 2022 until now.

Certification & Courses

  • Numerous certifications of international and Greek workshops / courses / seminars / specialized focus meetings in the entire spectrum of nuclear medicine and mainly at the setting of diagnosis-treatment (theranostics) regarding neuroendocrine tumors, prostate cancer, thyroid gland cancer and liver neoplasms using α- and β-radiation.

  • Invited speaker at international and Greek conferences and seminars – Invited chair president  at Greek conferences sessions.

Publications

  1. Prive, B. M., Muselaers, C. H., Meijer, D., van Gemert, W. A., Timmermans, B. J., Janssen, M., Jonker, M. A., van Oort, I. M., Mehra, N., Gerritsen, W.R., Alevroudis, E., Vrachimis, A., Gietema, J.A., Gotthardt, M., Vis, A. N., de Jong, I.G., Witjes, J.A., Noordzij W., Oprea-Lager, D. E., Nagarajah, J. (2024). Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer, a prospective randomized study (Bullseye). Nuklearmedizin-NuclearMedicine, 63(02), L35. DOI: 10.1055/s-0044-1782303

  2. Roll, W., Hadjitheodorou, P., Alevroudis, E., Kyrou, K., Pourkhessalian, M. R., Adamou, G., Fesas, A., Kalogirou, C., Schäfers, M., Vrachimis, A. (2024). [18F] FDG-und [18F] FAPI-74-PET bei Patienten mit Radioiod-refraktärem differenzierten Scilddrüsenkarzinom. Nuklearmedizin-NuclearMedicine, 63(02), P26. DOI: 10.1055/s-0044-1782433

  3. Alevroudis, E., Spei, M. E., Chatziioannou, S. N., Tsoli, M., Wallin, G., Kaltsas, G., & Daskalakis, K. (2021). Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis. Cancers, 13(8), 1813. https://doi.org/10.3390/cancers13081813.

  4. Meristoudis, G., Ilias, I., Zaromytidou, E., Alevroudis, E., & Notopoulos, A. (2021). Cholethorax with biliopleural communication detected on [99mTc]mebrofenin hepatobiliary scintigraphy. Nuclear medicine review. Central & Eastern Europe, 24(2), 124–125. https://doi.org/10.5603/NMR.2021.0031

  5. Protopapas, A. A., Papagiouvanni, I., Fragkou, N., Alevroudis, E., Sinakos, E., & Goulis, I. (2022). Estimation of glomerular filtration rate in patients with cirrhosis: evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate. European journal of gastroenterology & hepatology, 34(1), 84–91. https://doi.org/10.1097/MEG.0000000000001935

  6. Theodorakou, D., Stefanoyiannis, A., Manios, G., Georgakopoulos, A., Lamprakopoulos, G., Bacalis, S., Alevroudis, E., Chatziioannou, S. (2022). PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer (MCRPC): The Emerging Role of Terbium Isotopes. Physica Medica, 104, S36. DOI:10.1016/S1120-1797(22)03116-7.

  7. Tsoli, M., Kyriakopoulos, G., Daskalakis, K., Chatziioannou, S., Alevroudis, E., Nousiopoulou, E., Alexandraki, K., Koumarianou, A., Kaltsas, G. (2022, March). Correlation of loss of ATRX expression with scintigraphic imaging studies in pancreatic neuroendocrine neoplasms. In JOURNAL OF NEUROENDOCRINOLOGY (Vol. 34, pp. 120-120). 

  8. Alevroudis, E., Liotsou, T., Metaxas, M., Tsoli, M., Anagnostou, E., Kaltsas, G., & Chatziioannou, S. N. (2021, September). Meningiomas as Incidentalomas Visualized on Ga-68-DOTATOC-PET/CT. In European Journal of Nuclear Medicine and Molecular Imaging (Vol. 48, No. SUPPL 1, pp. S271-S271)

  9. Cholongitas, E., Ioannidou, M., Goulis, I., Chalevas, P., Ntogramatzi, F., Athanasiadou, Z., Notopoulos, A., Alevroudis, E., Sinakos, E., & Akriviadis, E. (2017). Comparison of creatinine and cystatin formulae with 51 Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis. Journal of gastroenterology and hepatology, 32(1), 191–198. https://doi.org/10.1111/jgh.13446

  10. Notopoulos, A., Likartsis, C., Zaromytidou, E., Petrou, I., Meristoudis, G., Alevroudis, E., Oikonomou, Z., Stavros, T., Psarras, K., & Papazoglou, K. (2015). The diagnostic performance of (99m)Tc-HMPAO radiolabeled leucocytes scintigraphy in the investigations of infection. A single center experience. Hellenic journal of nuclear medicine, 18 Suppl 1, 23–28.

Professional Memberships

  • Cyprus Medical Association, Panhellenic Medical Association and Athens Medical Association

  • Cyprus Society of Nuclear Medicine

  • Hellenic Society of Nuclear Medicine and Molecular Imaging 

  • Hellenic Society of Nuclear Medicine - Thessaloniki

  • European Association of Nuclear Medicine (EANM)

  • European Neuroendocrine Tumor Society (ENETS)


bottom of page